First-in-human, dose escalation, phase I study of an antibody-based immunotherapy in patients with solid tumor (Kopie)
Buyer: Bicony Therapeutics GmbH
- Published
- 19 November 2024
- Place of performance
- DED51
- Procedure
- Negotiated procedure
- Lots
- 1
- Documents
- 1
- Notice number
- 00703616-2024
- Reference
- 7d4d4fa1-74bc-412c-925c-279c672fac40
- Official source
- Official source
CPV codes
- 85145000Servicios prestados por laboratorios médicos
- 85148000Servicios de análisis médicos
Description
Conduct of a multicenter, first-in-human, dose escalation, phase I study of an antibody-based immunotherapy in patients with solid tumor (basket trial).
Official publications
- TED · 00703616-2024 · 19 November 2024
- OJS · 225/2024 · 19 November 2024
Other tenders from Bicony Therapeutics GmbH
Frequently asked questions
- Who is the buyer of this tender?
- The contracting authority is Bicony Therapeutics GmbH (European Union).
- How can I bid for public tenders in European Union?
- Bids are submitted through the official procurement portal of European Union. El Vínculo helps you find tenders and analyse their documents; submission always happens at the official source.
Get alerts for tenders like this
Create a free account and receive new tenders from European Union matching your business, every day.
Create a free account and receive new tenders from European Union matching your business, every day.